Navigation Links
Sinobiopharma Reports Highlights From Audited Financial Results for the Fiscal Year Ended May 31, 2009
Date:9/23/2009

NANTONG CITY, China, Sept. 23 /PRNewswire-Asia-FirstCall/ -- Sinobiopharma, Inc. ("Sinobiopharma" or the "Company") is pleased to report financial highlights from the audited financial results for the fiscal year ended May 31, 2009.

    Financial highlights include:
    -- Sales revenue increased to US$3,850,278 for the 12 months ended May 31,
       2009, from US$1,810,318 in the corresponding period ended May 31, 2008,
       a year-over-year increase of 112.69 percent.

    -- Gross profit increased to US$2,538,441, representing 66 percent of
       sales revenue, for the 12 months ended May 31, 2009, from US$580,915,
       representing 32 percent of revenue, in the corresponding period ended
       May 31, 2008.

    -- Net profit of the Company's wholly owned operating subsidiary, Dong
       Ying (Jiangsu) Pharmaceutical Co., Ltd., increased to US$1,019,507
       representing 26% of sales revenue, for the 12 months ended May 31, 2009,
       from -US$199,306 in the corresponding period ended May 31, 2008, a
       year-over-year increase of more than 400 percent.  However, the
       Company's overall net loss increased to US$2,140,237 for the 12 months
       ended May 31, 2009, of which one of the main expenses affecting the
       results of operations was the stock-based compensation charge of
       US$2,917,125, reflecting the vesting of stock options granted by the
       Company and professional fee of public company administration (audit,
       legal, etc.) of US$270,518.

    -- Increase in sales volume and the improvement in gross profit percentage
       are both due to growth in sales of Cisatracurium Besylate, a pre-
       surgical skeletal muscle relaxant.  Sales of this product increased to
       US$3,595,031 in the 12 months ended May 31, 2009, from US$1,364,165 in
       the 12 months ended May 31, 2008.  At the same time, as volume has
       increased, cost of manufacturing Cisatra
'/>"/>
SOURCE Sinobiopharma, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Emissary Capital Group Initiates Coverage on Sinobiopharma
2. Sinobiopharma Applies For Two Chinese Patents For Cisatracurium Besylate
3. Sinobiopharma Updates on Progress; Projects Increases in Sales and Revenues In 2009
4. Sinobiopharma Announces SFDA Approval of Anti-Hypertension Drug Perindopril
5. Sinobiopharma Secures Rights to Seven Key Patents
6. Sinobiopharma Reports a 141% Increase in Revenues From Unaudited Financial Results for the 9 Month Period Ended February 28, 2009
7. Sinobiopharma Reports a 41% Increase in Revenues From Unaudited Financial Results for the 9 Month Period Ended February 28, 2009
8. Sinobiopharma, Inc. Appoints New Director of Marketing
9. Sinobiopharma Signs Export Agreement With U.S. Pharmaceutical Supplier
10. Sinobiopharma Reports Financial Highlights for Six-Month Period Ending November 30, 2008
11. Economic Strength of Hawaii Seed Crop Industry Confirmed by Recent Reports
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)...  Neogen Corporation (NASDAQ: NEOG ) announced today ... relationship with Illumina (NASDAQ: ILMN ), the global ... will market and sell arrays with Neogen,s custom SNP ... to the global agrigenomics community. Neogen is ... ® genomics laboratory in Lincoln, Neb. ...
(Date:7/7/2015)... , ... July 07, 2015 , ... uBiome, the leading ... to $100,000 of microbiome sampling kits and full 16S laboratory analysis. The goal is ... The winner will also have access to their own dashboard, enabling them to view ...
(Date:7/7/2015)... ND (PRWEB) , ... July 07, 2015 , ... CSM, ... executive team as Vice President of Finance. Morse has an extensive background in financial ... industries to the CSM team. In his new role, Morse will oversee all financial ...
(Date:7/6/2015)... BELLINGHAM, Washington, USA, and CARDIFF, UK (PRWEB) , ... ... ... widely used in ophthalmology and other medical fields holds potential to reveal how ... new treatments and reduce stroke-induced damage to the brain. , A new article ...
Breaking Biology Technology:Neogen signs commercialization agreement with Illumina 2uBiome to Award Grant of up to $100k for Groundbreaking Microbiome Research 2uBiome to Award Grant of up to $100k for Groundbreaking Microbiome Research 3CSM Appoints Michael Morse as Vice President of Finance 2Reducing Stroke Damage May be Next Application for OCT Technology Now Widely Used in Eye and Vision Healthcare 2Reducing Stroke Damage May be Next Application for OCT Technology Now Widely Used in Eye and Vision Healthcare 3
... to testing for sleep-related illnesses , , SAN ... of in-home sleep testing and Continuous Positive Airway Pressure ... of the nation,s largest healthcare benefit providers. As a ... able to serve more patients with sleep-related illnesses such ...
... June 16 Strativa Pharmaceuticals, the proprietary products division ... Inc. (NYSE: PRX ), today announced that ... Drug Application (NDA) to the Food and Drug Administration ... buccal tablets, as planned. If approved, Strativa could ...
... , , Harness the Dual Benefits of Freshly ... CHICAGO, June 16 In today,s competitive environment and economic ... a promising new drug compound or chemical entity cannot be ... to do more with less, and productivity and cost savings ...
Cached Biology Technology:SleepQuest Signs National Contract With Aetna 2Strativa's Development Partner, BioAlliance Pharma, Submits Loramyc(R) NDA 2Celsis Outlines the Top Five Advantages of Cryo-plateable Hepatocytes 2Celsis Outlines the Top Five Advantages of Cryo-plateable Hepatocytes 3Celsis Outlines the Top Five Advantages of Cryo-plateable Hepatocytes 4
(Date:6/24/2015)... , June 24, 2015 The biologics safety ... major drivers for the market include growth of the ... new drug launches. Over the years, the number of ... 2001 and 2010, the FDA approved 225 drug applications ... WIPO, Europe accounted for 3,822 ...
(Date:6/24/2015)... -- Research and Markets( http://www.researchandmarkets.com/research/hhwlfj/huawei_ascend ... "Huawei Ascend Mate 7 Fingerprint Sensor - Reverse ... Huawei,s technological choice for the fingerprint sensor ... and Samsung,s one. The Ascend Mate 7 presents ... a main actor in capacitive sensing human interface ...
(Date:6/23/2015)... , June 22, 2015 ... the addition of the "Body-Worn Temperature Sensors ... Trends and Forecast 2014 - 2020" report ... strategic analysis of the global body-worn temperature sensors ... been segmented on the basis of types, care ...
Breaking Biology News(10 mins):Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 2Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 3Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 4Huawei Ascend Mate 7 Fingerprint Sensor - Reverse Costing Analysis 2Body-Worn Temperature Sensors Market - Global Industry Analysis 2
... Since the Civil War, the stethoscope has been a ... doctor may be toting another valuable diagnostic tool: a pocket-sized ... of internal medicine at Eastern Virginia Medical School, believes that ... they will become commonplace," he predicts. Dr. Levitov, a ...
... In nature, it,s a dog-eat-dog world, even in ... to disable each other, according to a new study ... in the journal Nature . "The ... ways to control disease-causing pathogens," said Stephanie K. Aoki, ...
... contaminants in the recreational waters at Presque Isle State ... Protection Agency, it was announced today. The ... Science Consortium and Penn State Behrend, will be used ... important human and environmental health implications. Dr. Steven Mauro, ...
Cached Biology News:Author predicts widespread acceptance of pocket-sized ultrasound machines 2Bacteria use 'toxic darts' to disable each other, according to UCSB scientists 2Study eyes fluoxetine in recreational waters 2
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
Biology Products: